These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7935030)

  • 1. Effect of conjugated estrogens with and without medrogestone: a prospective study.
    van der Mooren MJ; Leuven JA; Rolland R
    Maturitas; 1994 May; 19(1):33-42. PubMed ID: 7935030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of medrogestone on plasma lipids and lipoproteins in postmenopausal women using conjugated estrogens: an open randomized comparative study.
    Gevers Leuven JA; van der Mooren MJ; Buytenhek R
    Fertil Steril; 1995 Sep; 64(3):525-31. PubMed ID: 7641905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of combined conjugated estrogen-medrogestone replacement therapy on lipid profiles, climacteric symptoms and the endometrium].
    Belaisch J; Nappi C; Affinito P; De Gezelle H; Botelho M; Oliveira HM; Martinez-Oliveira J; Gonzaga F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):29-40. PubMed ID: 10675831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of continuous medroxyprogesterone acetate on lipoprotein metabolism in postmenopausal women receiving estrogen.
    Wakatsuki A; Sagara Y
    Maturitas; 1996 Aug; 25(1):35-44. PubMed ID: 8887307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women.
    Sendag F; Karadadas N; Ozsener S; Bilgin O
    Arch Gynecol Obstet; 2002 Jan; 266(1):38-43. PubMed ID: 11998963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of two hormone replacement therapy regimens, oral oestradiol valerate and cyproterone acetate versus transdermal oestradiol and oral dydrogesterone, on lipid metabolism.
    Schram JH; Boerrigter PJ; The TY
    Maturitas; 1995 Sep; 22(2):121-30. PubMed ID: 8538480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum lipoprotein effects of conjugated estrogen and a sequential conjugated estrogen-medrogestone regimen in hysterectomized postmenopausal women.
    Sonnendecker EW; Polakow ES; Benadé AJ; Simchowitz E
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 1):1128-34. PubMed ID: 2543223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrauterine administration of levonorgestrel in two low doses in HRT. A randomized clinical trial during one year: effects on lipid and lipoprotein metabolism.
    Wollter-Svensson LO; Stadberg E; Andersson K; Mattsson LA; Odlind V; Persson I
    Maturitas; 1995 Nov; 22(3):199-205. PubMed ID: 8746877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parameters of lipid metabolism in postmenopausal women on oral or transdermal hormone replacement with or without progesterone].
    Foth D; Römer T; Benthin A
    Zentralbl Gynakol; 2000; 122(9):483-8. PubMed ID: 11050765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of medrogestone and conjugated oestrogens on serum lipid and lipoprotein concentrations.
    Teichmann AT; Wieland H; Cremer P; Hinney B; Kuhn W; Seidel D
    Maturitas; 1985 Nov; 7(4):343-50. PubMed ID: 3001482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal women.
    Moorjani S; Dupont A; Labrie F; De Lignieres B; Cusan L; Dupont P; Mailloux J; Lupien PJ
    J Clin Endocrinol Metab; 1991 Aug; 73(2):373-9. PubMed ID: 1649840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.
    Godsland IF
    Fertil Steril; 2001 May; 75(5):898-915. PubMed ID: 11334901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in normal lipid profile of menopausal women with combined hormone replacement therapy. Comparative clinical trial of two hormonal combinations (conjugated estrogens/medroxyprogesterone acetate versus estradiol valerate/cyproterone acetate).
    Alwers R; Urdinola J; Onatra W; Sánchez F; Posso H
    Maturitas; 1999 May; 32(1):41-50. PubMed ID: 10423715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of transdermal and oral estrogens on serum lipids and lipoproteins in postmenopausal women.
    Adami S; Rossini M; Zamberlan N; Bertoldo F; Dorizzi R; Lo Cascio V
    Maturitas; 1993 Nov; 17(3):191-6. PubMed ID: 8133793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new peroral estrogen/progestin combination for postmenopausal hormonal substitution: an open multicentric field study.
    Haenggi W; Birkhaeuser MH
    Maturitas; 1993 Mar; 16(2):111-22. PubMed ID: 8387150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phasic serum lipid excursions occur during cyclical oral conjugated oestrogens but not during transdermal oestradiol sequentially combined with oral medroxyprogesterone acetate.
    Lemay A; Dodin S; Cédrin I; T-Lemay L
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):341-51. PubMed ID: 7750187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lipids and lipoproteins in postmenopausal women receiving transdermal oestrogen in combination with a levonorgestrel-releasing intrauterine device.
    Raudaskoski TH; Tomás EI; Paakkari IA; Kauppila AJ; Laatikainen TJ
    Maturitas; 1995 Jun; 22(1):47-53. PubMed ID: 7666816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 2-year study of lipid and lipoprotein changes in postmenopausal women with tibolone and estrogen-progestin.
    Milner MH; Sinnott MM; Cooke TM; Kelly A; McGill T; Harrison RF
    Obstet Gynecol; 1996 Apr; 87(4):593-9. PubMed ID: 8602314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy: lipid responses to continuous combined oestrogen and progestogen versus oestrogen monotherapy.
    Metka M; Hanes V; Heytmanek G
    Maturitas; 1992 Aug; 15(1):53-9. PubMed ID: 1326708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of different hormone replacement regimens on postmenopausal women with abnormal lipid levels. Menopause Study Group.
    Pickar JH; Wild RA; Walsh B; Hirvonen E; Lobo RA
    Climacteric; 1998 Mar; 1(1):26-32. PubMed ID: 11913407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.